Paper8329702
Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7.
Komatsu N and 9 others. Blood, 1993. Cited by 180 papers, by iCite.
Cite this record
ConductScience Library. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Papers, record 8329702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8329702
- Cell line
- UT-7/Epo4 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythropoietin | Major topic |
| Leukemia, Megakaryoblastic, Acute | Major topic |
| Butyrates | |
| Butyric Acid | |
| Cell Differentiation | |
| Cell Division | |
| DNA-Binding Proteins | |
| Erythroid-Specific DNA-Binding Factors | |
| Gene Expression | |
| Granulocyte-Macrophage Colony-Stimulating Factor | |
| Hemoglobins | |
| Humans | |
| Interleukin-3 | |
| Nucleic Acid Hybridization | |
| Proto-Oncogene Proteins | |
| Proto-Oncogene Proteins c-myb | |
| RNA, Messenger | |
| Receptors, Erythropoietin | |
| Recombinant Proteins | |
| Tetradecanoylphorbol Acetate | |
| Transcription Factors | |
| Tumor Cells, Cultured |
Source PubMed
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 180 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41556618 | Tetravalent antibodies are more potent and efficacious erythropoiesis-stimulating agents than erythropoietin in vivo. | Protein Sci | 2026 | https://conductscience.org/library/papers/41556618 | PubMed |
| 40960423 | An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo. | Protein Sci | 2025 | https://conductscience.org/library/papers/40960423 | PubMed |
| 40594492 | Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594492 | PubMed |
| 40540751 | Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors. | Blood | 2025 | https://conductscience.org/library/papers/40540751 | PubMed |
| 39847438 | Human oncostatin M deficiency underlies an inherited severe bone marrow failure syndrome. | J Clin Invest | 2025 | https://conductscience.org/library/papers/39847438 | PubMed |
| 39652455 | BCR::ABL1-induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia. | Cancer Sci | 2025 | https://conductscience.org/library/papers/39652455 | PubMed |
| 39337361 | The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337361 | PubMed |
| 37443738 | EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27Kip1. | Cells | 2023 | https://conductscience.org/library/papers/37443738 | PubMed |
| 36359207 | Systemic Optimization of Gene Electrotransfer Protocol Using Hard-to-Transfect UT-7 Cell Line as a Model. | Biomedicines | 2022 | https://conductscience.org/library/papers/36359207 | PubMed |
| 34165774 | MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations. | Int J Hematol | 2021 | https://conductscience.org/library/papers/34165774 | PubMed |
| 32625106 | N-Methyl-D-Aspartate Receptors in Hematopoietic Cells: What Have We Learned? | Front Physiol | 2020 | https://conductscience.org/library/papers/32625106 | PubMed |
| 32473295 | Assessment and streamlined preparation of low-cytotoxicity lentiviral vectors for mobilized human hematopoietic stem cell transduction. | Exp Hematol | 2020 | https://conductscience.org/library/papers/32473295 | PubMed |
| 32259549 | Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis. | Exp Hematol | 2020 | https://conductscience.org/library/papers/32259549 | PubMed |
| 32027948 | Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling. | Cell Signal | 2020 | https://conductscience.org/library/papers/32027948 | PubMed |
| 30944118 | Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis. | Cancer Discov | 2019 | https://conductscience.org/library/papers/30944118 | PubMed |
| 30618479 | Optimizing Workflows for LC/MS Analysis of Co-Immunoprecipitated Protein Complexes - "Soap Opera(tions)". | J Proteomics Bioinform | 2018 | https://conductscience.org/library/papers/30618479 | PubMed |
| 30530752 | Single-cell analyses demonstrate that a heme-GATA1 feedback loop regulates red cell differentiation. | Blood | 2019 | https://conductscience.org/library/papers/30530752 | PubMed |
| 30030607 | Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassay. | Pediatr Nephrol | 2018 | https://conductscience.org/library/papers/30030607 | PubMed |
| 29296963 | Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells. | Blood Adv | 2017 | https://conductscience.org/library/papers/29296963 | PubMed |
| 29078273 | Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/29078273 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CSF2 | 1437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 | NCBI Gene |
| EPOR | 2057 | PubTator's text mining | https://conductscience.org/library/genes/2057 | NCBI Gene |
| IL3 | 3562 | PubTator's text mining | https://conductscience.org/library/genes/3562 | NCBI Gene |
| MYB | 4602 | PubTator's text mining | https://conductscience.org/library/genes/4602 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8329702
GET https://conductscience.org/api/papers/v1/8329702/cited_by?page=2